Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04472364Not ApplicableCompleted

HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding

Role: collaborator

NCT06086184Not ApplicableUnknown

Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum Disorder

Role: lead

NCT04745507Unknown

Implementation, Efficacy and Costs of Inpatient Equivalent Home-Treatment in German Mental Health Care

Role: lead

NCT04620395Not ApplicableUnknown

Percutaneous Punch Biopsy for Diagnosis of Septic and Aseptic Prosthetic Joint Failure

Role: lead

NCT01722786Completed

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists

Role: collaborator

NCT04337567Not ApplicableUnknown

Radiofrequency Ablation Versus Balloon Cryoablation in Elderly Patients With Atrial Fibrillation

Role: lead

NCT02785731Completed

Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.

Role: collaborator

All 7 trials loaded